Literature DB >> 15953464

Solitary superficial angiomyxoma in the eyelid.

Hunter K L Yuen1, W Cheuk, Fiona O J Luk, Christina S K Wat, K C Auyeung, Dennis S C Lam.   

Abstract

PURPOSE: To report the clinicopathologic features of a solitary superficial angiomyxoma arising in the eyelid.
DESIGN: Case report.
METHODS: A retrospective review of the clinical and pathologic features of a patient with solitary superficial angiomyxoma in the eyelid.
RESULTS: A 47-year-old male presented with a right upper lid mass for 6 months. Excisional biopsy was performed, and microscopic examination revealed a tumor comprising loose spindle or stellate-shaped cells in myxoid stroma sprinkled with small numbers of neutrophils. The tumor cells were negative for smooth muscle actin, desmin, S-100 protein, and CD34 on immunostaining.
CONCLUSIONS: Ophthalmologists should be aware of superficial angiomyxoma as a rare cutaneous tumor with a tendency for local recurrence. Multiple lesions and occurrence in the external ear can be associated with the Carney's complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953464     DOI: 10.1016/j.ajo.2004.12.019

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Rare Case of Isolated Superficial Angiomyxoma of the Eyelid.

Authors:  Young In Yun; Kyu Sang Lee; Sang In Khwarg; Namju Kim
Journal:  Korean J Ophthalmol       Date:  2020-06

2.  Superficial angiomyxoma of the posterior neck.

Authors:  Young Joong Hwang; Hong Won Lee; Il Seok Lee; Sung Gyun Jung; Hye Kyung Lee
Journal:  Arch Craniofac Surg       Date:  2021-02-20

3.  Conjunctival myxoid stromal tumor of the palpebral conjunctiva: A case report.

Authors:  Pamela S Martin; Cooper D Rodgers; Aldo Fantin; Gulsun Erdag
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-18

4.  Neurothekeoma of the eyelid: a case report.

Authors:  Sunu Mathew; B N Nandeesh; Usha Vasu; Shon George Michael
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.